Type
. Activity of three new rifamycin derivates on the experimental infection by Mycobacterium leprae. Annales de la Societe belge de medecine tropicale. 1977;57(3):169-73.
Type
. Recent advances in experimental leprosy. Southern medical journal. 1976;69(8):993-6.
Type
. IL-15, an immunomodulator of T cell responses in intracellular infection. Journal of immunology (Baltimore, Md. : 1950). 1997;158(2):800-6.
Type
. Reactivity of a population of armadillo lymphocytes with an antibody to human gamma,delta T-cells. Clinical immunology and immunopathology. 1997;82(1):68-72.
Type
. HLA-DR polymorphism modulates the cytokine profile of Mycobacterium leprae HSP-reactive CD4+ T cells. Clinical immunology and immunopathology. 1997;82(1):60-7.
Type
. Carville: 100 years of excellence. Journal of the American Academy of Dermatology. 1997;36(1):126-30.
Type
. Infectious diseases. Forward to the past. Lancet (London, England). 1996;348 Suppl 2:sII11.
Type
. A 35-kilodalton protein is a major target of the human immune response to Mycobacterium leprae. Infection and immunity [Internet]. 1996;64(12):5171-7. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC174504/pdf/645171.pdf
Type
. Disease concomitance in psoriasis. Journal of the American Academy of Dermatology. 1996;35(5 Pt 1):790-1.
Type
. Serum zinc, copper, magnesium, proteins and superoxide dismutase in leprosy patients on multidrug therapy--a follow-up study. Indian journal of leprosy. 1996;68(4):325-33.